0001209191-23-058816.txt : 20231215 0001209191-23-058816.hdr.sgml : 20231215 20231215170903 ACCESSION NUMBER: 0001209191-23-058816 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231120 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HEDRICK MARC H CENTRAL INDEX KEY: 0001203672 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34375 FILM NUMBER: 231491271 MAIL ADDRESS: STREET 1: C/O CYTORI THERAPEUTICS, INC. STREET 2: 3020 CALLAN ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001095981 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330827593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 BUSINESS PHONE: 737.255.7194 MAIL ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 FORMER COMPANY: FORMER CONFORMED NAME: CYTORI THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050712 FORMER COMPANY: FORMER CONFORMED NAME: MACROPORE INC DATE OF NAME CHANGE: 20010320 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-11-20 0 0001095981 PLUS THERAPEUTICS, INC. PSTV 0001203672 HEDRICK MARC H C/O PLUS THERAPEUTICS INC. 4200 MARATHON BOULEVARD, SUITE 200 AUSTIN TX 78756 1 1 0 0 Chief Executive Officer 0 Common Stock 2023-11-20 4 S 0 2068 1.9597 D 170 D The transactions reflect inadvertent trades made by the reporting person's custodian without authorization. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.9601 or $1.9768 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Andrew Sims, as attorney-in-fact 2023-12-15